Stock analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report released on Monday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
AMPE opened at $0.13 on Monday. The stock has a market cap of $148,200.00, a PE ratio of -0.01 and a beta of 2.15. Ampio Pharmaceuticals has a 1 year low of $0.11 and a 1 year high of $8.30. The stock’s 50 day simple moving average is $0.23 and its 200-day simple moving average is $1.14.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last released its quarterly earnings data on Wednesday, March 27th. The company reported ($2.48) earnings per share (EPS) for the quarter.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- Market Cap Calculator: How to Calculate Market Cap
- Chipotle Mexican Grill Stock Split: Where Does it Go From Here?
- What Are Dividend Challengers?
- Arm Holdings and Micron: Top 2 AI Stocks to Buy and Hold
- Where to Find Earnings Call Transcripts
- Best Buy Stock May Be Best Bought Before the Holiday Season
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
